Cargando…

Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study

BACKGROUND: The efficacy of medical treatment among obese men with lower urinary tract symptoms (LUTS) has been less clear, especially regarding the improvement of QoL. We aimed to investigate the difference in efficacy and consequent satisfaction of life quality after medical treatment of male LUTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jae Heon, Choi, Hoon, Sun, Hwa Yeon, Doo, Seung Whan, Yoon, Jong Hyun, Yang, Won Jae, Yoo, Byung Wook, Kim, Joyce Mary, Kwon, Soon-Sun, Song, Eun Seop, Lee, Hong Jun, Lim, Ik Sung, Song, Yun Seob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126641/
https://www.ncbi.nlm.nih.gov/pubmed/25099073
http://dx.doi.org/10.1186/1471-2490-14-60
_version_ 1782329939129794560
author Kim, Jae Heon
Choi, Hoon
Sun, Hwa Yeon
Doo, Seung Whan
Yoon, Jong Hyun
Yang, Won Jae
Yoo, Byung Wook
Kim, Joyce Mary
Kwon, Soon-Sun
Song, Eun Seop
Lee, Hong Jun
Lim, Ik Sung
Song, Yun Seob
author_facet Kim, Jae Heon
Choi, Hoon
Sun, Hwa Yeon
Doo, Seung Whan
Yoon, Jong Hyun
Yang, Won Jae
Yoo, Byung Wook
Kim, Joyce Mary
Kwon, Soon-Sun
Song, Eun Seop
Lee, Hong Jun
Lim, Ik Sung
Song, Yun Seob
author_sort Kim, Jae Heon
collection PubMed
description BACKGROUND: The efficacy of medical treatment among obese men with lower urinary tract symptoms (LUTS) has been less clear, especially regarding the improvement of QoL. We aimed to investigate the difference in efficacy and consequent satisfaction of life quality after medical treatment of male LUTS according to obesity. METHODS: An 8-week prospective study was performed for a total of 140 patients >50 years old with International Prostate Symptom Scores (IPSS) > 12 points and prostate volume > 20 mL. Obesity was determined by either body mass index (BMI) or waist circumference (WC). Patients were divided into 2 groups according to BMI or WC. Patients received tamsulosin at a dose of 0.4 mg daily for 8 weeks. The changes from baseline in the IPSS, maximal urinary flow rate (Qmax), post-void residual volume, questionnaire of quality of life (QoL), and King’s Health Questionnaire (KHQ) were analyzed. RESULTS: Of the 150 enrolled patients, 96 completed the study. Seventy-five patients (78.1%) had BMI ≥ 23 kg/m(2), and 24 (25.0%) had WC > 90 cm. Overall, the IPSS, IPSS QoL, and total KHQ showed significant improvement. Obese (BMI ≥ 23 kg/m(2)) and non-obese (BMI < 23 kg/m(2)) both showed improvement of the IPSS and IPSS QoL scores, but only the obese (BMI ≥ 23 kg/m(2)) group showed improvement of the total KHQ score (P < 0.001 vs. P = 0.55). Only the obese (WC > 90 cm) group showed improvement of the IPSS and total KHQ scores (P < 0.001). CONCLUSIONS: Our preliminary study showed the different efficacy of an alpha-blocker for improvement of LUTS and life quality according to obesity. Obese patients, defined by BMI or WC, showed the tendency toward a more favorable improvement of LUTS and life quality. TRIAL REGISTRATION: Current Controlled Trials 2010–058. Registered 2 September 2010 in Soonchunhyang Univeristy Hospital
format Online
Article
Text
id pubmed-4126641
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41266412014-08-09 Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study Kim, Jae Heon Choi, Hoon Sun, Hwa Yeon Doo, Seung Whan Yoon, Jong Hyun Yang, Won Jae Yoo, Byung Wook Kim, Joyce Mary Kwon, Soon-Sun Song, Eun Seop Lee, Hong Jun Lim, Ik Sung Song, Yun Seob BMC Urol Research Article BACKGROUND: The efficacy of medical treatment among obese men with lower urinary tract symptoms (LUTS) has been less clear, especially regarding the improvement of QoL. We aimed to investigate the difference in efficacy and consequent satisfaction of life quality after medical treatment of male LUTS according to obesity. METHODS: An 8-week prospective study was performed for a total of 140 patients >50 years old with International Prostate Symptom Scores (IPSS) > 12 points and prostate volume > 20 mL. Obesity was determined by either body mass index (BMI) or waist circumference (WC). Patients were divided into 2 groups according to BMI or WC. Patients received tamsulosin at a dose of 0.4 mg daily for 8 weeks. The changes from baseline in the IPSS, maximal urinary flow rate (Qmax), post-void residual volume, questionnaire of quality of life (QoL), and King’s Health Questionnaire (KHQ) were analyzed. RESULTS: Of the 150 enrolled patients, 96 completed the study. Seventy-five patients (78.1%) had BMI ≥ 23 kg/m(2), and 24 (25.0%) had WC > 90 cm. Overall, the IPSS, IPSS QoL, and total KHQ showed significant improvement. Obese (BMI ≥ 23 kg/m(2)) and non-obese (BMI < 23 kg/m(2)) both showed improvement of the IPSS and IPSS QoL scores, but only the obese (BMI ≥ 23 kg/m(2)) group showed improvement of the total KHQ score (P < 0.001 vs. P = 0.55). Only the obese (WC > 90 cm) group showed improvement of the IPSS and total KHQ scores (P < 0.001). CONCLUSIONS: Our preliminary study showed the different efficacy of an alpha-blocker for improvement of LUTS and life quality according to obesity. Obese patients, defined by BMI or WC, showed the tendency toward a more favorable improvement of LUTS and life quality. TRIAL REGISTRATION: Current Controlled Trials 2010–058. Registered 2 September 2010 in Soonchunhyang Univeristy Hospital BioMed Central 2014-08-06 /pmc/articles/PMC4126641/ /pubmed/25099073 http://dx.doi.org/10.1186/1471-2490-14-60 Text en Copyright © 2014 Kim et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kim, Jae Heon
Choi, Hoon
Sun, Hwa Yeon
Doo, Seung Whan
Yoon, Jong Hyun
Yang, Won Jae
Yoo, Byung Wook
Kim, Joyce Mary
Kwon, Soon-Sun
Song, Eun Seop
Lee, Hong Jun
Lim, Ik Sung
Song, Yun Seob
Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study
title Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study
title_full Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study
title_fullStr Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study
title_full_unstemmed Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study
title_short Measuring the improvement in health-related quality of life using King’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study
title_sort measuring the improvement in health-related quality of life using king’s health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126641/
https://www.ncbi.nlm.nih.gov/pubmed/25099073
http://dx.doi.org/10.1186/1471-2490-14-60
work_keys_str_mv AT kimjaeheon measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT choihoon measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT sunhwayeon measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT dooseungwhan measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT yoonjonghyun measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT yangwonjae measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT yoobyungwook measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT kimjoycemary measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT kwonsoonsun measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT songeunseop measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT leehongjun measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT limiksung measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy
AT songyunseob measuringtheimprovementinhealthrelatedqualityoflifeusingkingshealthquestionnaireinnonobeseandobesepatientswithlowerurinarytractsymptomsafteralphaadrenergicmedicationapreliminarystudy